New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
Shape
US Flag

NYSE

Unprofitable

Unprofitable

5B

Biotechnology

Next Earning date - 12 Nov 2024

5B

Biotechnology

Next Earning date - 12 Nov 2024

52.84USD
Shape0.48 ( 0.92%)
favorite-chart

Relative Strenght

87
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated October 27, 2024
1W 2.92 % 1M 5.74 % 3M 33.03 % 1Y 91.24 %

Key Metrics

Shape
  • Market Cap

    5.33B


  • Shares Outstanding

    100.95M


  • Share in Float

    87.92M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    52.84


  • Average Volume

    992668


  • Beta

    4.109


  • Range

    25.97-62.21


  • Industry

    Biotechnology


  • Website

    https://www.biohavenpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

12.09x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-9.3

EPS

How BHVN compares to sector?

P/E Ratio

Relative Strength

Shape

BHVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$22M

ShapeNaN%

2025-Revenue

$6.45

Shape-77%

2025-EPS

$16M

Shape105%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

initialise

Previous: Not converted

2024-09-16

Now: Buy

Bernstein

initialise

Previous: Not converted

2024-09-04

Now: Outperform

Morgan Stanley

initialise

Previous: Not converted

2024-07-24

Now: Overweight

BTIG

initialise

Previous: Not converted

2022-12-02

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.75
vs -2.63

Q4.22

arrow
arrow

N/A

-3.32
vs -3.01

Q1.23

arrow
arrow

N/A

-1.03
vs -2.97

Q2.23

arrow
arrow

N/A

-1.32
vs -6.21

Q3.23

arrow
arrow

N/A

-1.50
vs -1.75

Q4.23

arrow
arrow

N/A

-1.81
vs -3.32

Q1.24

arrow
arrow

N/A

-2.20
vs -1.03

Q2.24

arrow
arrow

N/A

-3.64
vs -1.32

Q3.24

arrow
arrow

N/A

-1.70
vs -1.50

Q4.24

arrow
arrow

N/A

-1.62
vs -1.81

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-100%

NA  vs 135.7M

Q4.22

arrow
arrow

-213%

-215079000.00  vs 190M

Q1.23

arrow
arrow

-100%

NA  vs 318.9M

Q2.23

arrow
arrow

-100%

NA  vs 215.1M

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

+100%

NA  vs -215079000

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

1.7K  vs NA

Q4.24

arrow
arrow

NA

12.5M  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-69%

-0.69
vs -0.78

Q4.22

arrow
arrow

-37%

-0.37
vs -0.69

Q1.23

arrow
arrow

-15%

-0.15
vs -0.37

Q2.23

arrow
arrow

-23%

-0.23
vs -0.15

Q3.23

arrow
arrow

-35%

-0.35
vs -0.23

Q4.23

arrow
arrow

-34%

-0.34
vs -0.35

Q1.24

arrow
arrow

-60%

-0.60
vs -0.34

Q2.24

arrow
arrow

-83%

-0.83
vs -0.60

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

259

259
vs 342

-24%

Q4.22

arrow
arrow

191

191
vs 259

-26%

Q1.23

arrow
arrow

191

191
vs 191

NA

Q2.23

arrow
arrow

205

205
vs 191

7%

Q3.23

arrow
arrow

197

197
vs 205

-4%

Q4.23

arrow
arrow

231

231
vs 197

17%

Q1.24

arrow
arrow

264

264
vs 231

14%

Q2.24

arrow
arrow

233

233
vs 264

-12%

Earnings Growth

Latest News